BG
Bellevue Group’s Beam Therapeutics BEAM Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $49.1M | Buy |
2,889,288
+493,358
| +21% | +$8.39M | 1.08% | 22 |
|
|
2025
Q1 | $46.8M | Buy |
2,395,930
+877,809
| +58% | +$17.1M | 1.05% | 24 |
|
|
2024
Q4 | $37.6M | Hold |
1,518,121
| – | – | 0.72% | 30 |
|
|
2024
Q3 | $37.2M | Buy |
1,518,121
+100,000
| +7% | +$2.45M | 0.6% | 48 |
|
|
2024
Q2 | $33.2M | Buy |
1,418,121
+225,000
| +19% | +$5.27M | 0.54% | 54 |
|
|
2024
Q1 | $39.4M | Buy |
1,193,121
+498,300
| +72% | +$16.5M | 0.6% | 55 |
|
|
2023
Q4 | $18.9M | Hold |
694,821
| – | – | 0.29% | 76 |
|
|
2023
Q3 | $16.7M | Sell |
694,821
-600
| -0.1% | -$14.4K | 0.27% | 76 |
|
|
2023
Q2 | $22.2M | Hold |
695,421
| – | – | 0.32% | 71 |
|
|
2023
Q1 | $21.3M | Sell |
695,421
-1,300
| -0.2% | -$39.8K | 0.31% | 78 |
|
|
2022
Q4 | $27.2M | Buy |
696,721
+125,000
| +22% | +$4.89M | 0.36% | 73 |
|
|
2022
Q3 | $27.2M | Sell |
571,721
-900
| -0.2% | -$42.9K | 0.39% | 69 |
|
|
2022
Q2 | $22.2M | Sell |
572,621
-10,200
| -2% | -$395K | 0.31% | 82 |
|
|
2022
Q1 | $33.4M | Sell |
582,821
-30,000
| -5% | -$1.72M | 0.39% | 78 |
|
|
2021
Q4 | $48.8M | Hold |
612,821
| – | – | 0.5% | 66 |
|
|
2021
Q3 | $53.3M | Hold |
612,821
| – | – | 0.54% | 59 |
|
|
2021
Q2 | $78.9M | Buy |
612,821
+46,000
| +8% | +$5.92M | 0.77% | 42 |
|
|
2021
Q1 | $45.4M | Buy |
566,821
+170,000
| +43% | +$13.6M | 0.48% | 68 |
|
|
2020
Q4 | $32.4M | Buy |
+396,821
| New | +$32.4M | 0.37% | 76 |
|